Stocklytics Platform
Asset logo for symbol PEPG
Asset logo for symbol PEPG


Key Stats
Prev. Close$17.86
Next Earnings Date-
Dividend Yield %-
PE Ratio-
Day Range17.86
52 Week Range3.72
EBITDA Margin %-
Gross Profit-
Payout Ratio-
Industry average yield2.86%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis


Summarizing what the indicators are suggesting.

Strong Buy
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Strong Sell

Stock Performance

US Healthcare Sectorarrow_drop_down0.16%
US Marketarrow_drop_up0.90%
PEPG / Market
PEPG lose to the US Market which returned 0.90% over the last twenty four hours.
PEPG / Healthcare Sector
PEPG lose to the US Healthcare sector which returned -0.16% over the last twenty four hours.

PepGen (PEPG) Statistics

PepGen Inc., ticker symbol PEPG, is a biotechnology company that focuses on developing and commercializing peptide-based therapies for rare genetic diseases. The company's valuation metrics indicate its financial standing and market performance. One important metric is the enterprise value to EBITDA ratio, which measures the company's total value compared to its operating earnings. This ratio helps investors assess whether the stock is overvalued or undervalued. Additionally, PEPG's profit margin is a key statistic that shows the company's ability to generate profits from its revenue. A higher profit margin indicates better financial health. Another aspect to consider is PEPG's total debt, which reveals the company's level of financial leverage. Lower debt levels are generally seen as favorable as the company has less financial risk. Moreover, PEPG's gross profit measures the amount of revenue left after subtracting the cost of goods sold. This metric provides insights into the company's operational efficiency and profitability. Overall, understanding these valuation metrics and fundamentals can aid investors in evaluating PEPG's financial standing and potential for future growth.

PepGen Inc. is led by an experienced CEO who plays a crucial role in the company's success. The CEO brings a wealth of knowledge and expertise to drive PEPG's strategic vision and execution. With a deep understanding of the biotechnology industry and a track record of leadership, the CEO ensures that PEPG remains at the forefront of innovation in peptide-based therapies. Through effective decision-making and collaboration with the management team, the CEO guides PEPG's operations, research, and development efforts. By focusing on achieving key milestones and delivering value to shareholders, the CEO plays a vital role in shaping PEPG's future. With a strong leadership team in place, PepGen Inc. is well-positioned for continued growth and success.

add PepGen to watchlist

Keep an eye on PepGen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

How has PepGen (PEPG) stock's performance compared to its sector and the market over the past year?

Over the past year, PepGen (PEPG) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 27.74%, PepGen has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 49.41%, it has fallen short of the market average. This comparison highlights PepGen's performance relative to both its sector and the overall market over the last year.

What is the PE ratio of PepGen (PEPG) stock?

The PE ratio for PepGen (PEPG) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

What is the EPS of PepGen (PEPG) stock?

The Earnings Per Share (EPS) for PepGen (PEPG), calculated on a diluted basis, is -$3.24. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

What is the operating margin of PepGen (PEPG) stock?

The operating margin for PepGen (PEPG) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

What is the EBITDA of PepGen (PEPG) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of PepGen (PEPG) is -$85.12M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

How much debt does PepGen (PEPG) have?

PepGen (PEPG) has a total debt of $19.77M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$114.08M.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level